Dr. Deepinder Goyal, MD

Dr. Goyal practices at Gastro Health in Kissimmee, Florida.

Dr. Goyal's NPI, 1538323399, was assigned on July 10, 2008. Dr. Goyal graduated from Dayanand Medical College in 2004. Dr. Goyal's Texas license number on file is Q5388.

Dr. Goyal's primary practice is Gastro Health, at 710 Oak Commons Blvd, Kissimmee, FL 34741 in Osceola County. The practice phone is (305) 913-0666.

Dr. Goyal's primary practice is Gastro Health in Kissimmee, Florida. Dr. Goyal is also affiliated with AdventHealth Orlando. The medical group on file is Gastro Health. Dmand AI also links Dr. Goyal to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goyal practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Goyal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Goyal is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Goyal's licenses on file in 5 states: Texas, California, Florida, Illinois and Ohio.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Goyal treats.

CMS data shows 523 Medicare services from Dr. Goyal across 9 procedure codes in 2024, for 273 Medicare patients. Medicare paid $54,827 for them.

CMS counts 273 Medicare patients who saw Dr. Goyal in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goyal's median patient age at 60, with 56% women.

In 2024, Dr. Goyal wrote 1,216 Medicare Part D claims for 483 patients. 73% of them were for generic drugs. CMS names the drug for 1,028 of them, across 21 drugs with 11 or more claims each, at $491,864 in total drug cost. In 2023, CMS named 826 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Goyal for performance year 2024, reported as part of a group. Dr. Goyal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 158 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Goyal, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Goyal in 2017. Dr. Goyal's most frequent co-authors are Stuart Kevin Amateau, MD, PhD and Vikesh K. Singh, MD, MS.

CMS Open Payments shows 436 general payments to Dr. Goyal from 44 drug and device companies from 2016 to 2025. Grants make up the largest share, 81% of the total. Pentax of America, Inc. paid the most, $50,960.

Dr. Goyal graduated from Dayanand Medical College in 2004.

Dr. Goyal is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.